Docosahexaenoic Acid Supplementation for Neonatal Hyperbilirubinemia: A Double-Blind, Randomized Clinical Trial

YQ Chi, Y Yao, WH Zhang, ZH Zhang… - Clinical …, 2024 - journals.sagepub.com
Docosahexaenoic acid (DHA) is an essential component for brain development during fetal
and early postnatal life. Hyperbilirubinemia is characterized by abnormally high levels of …

The protective effect of docosahexaenoic acid on the bilirubin neurotoxicity

C Becerir, İ Kılıç, Ö Şahin, Ö Özdemir… - Journal of Enzyme …, 2013 - Taylor & Francis
Usually, all newborns demonstrate high serum unconjugated bilirubin (UCB) level. UCB
may induce adverse effects in the central nervous system. We aimed to evaluate the …

[HTML][HTML] Neurotoxicity of Unconjugated Bilirubin in Neonatal Hypoxic-Ischemic Brain Injury in vitro

C Dani, S Pratesi, G Mannaioni, E Gerace - Frontiers in Pediatrics, 2021 - frontiersin.org
Background: The pathophysiology of bilirubin neurotoxicity in course of hypoxic–ischemic
encephalopathy (HIE) in term and preterm infants is still poorly understood. We …

Effects of Two Different Doses of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates with Glucose-6-phosphate Dehydrogenase Deficiency Treated with …

R Farhadi, E Keyhanian, M Naderisorki… - Global Pediatric …, 2023 - journals.sagepub.com
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the causes of severe
hyperbilirubinemia, prolonged jaundice, and bilirubin-induced encephalopathy in neonates …

Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose‐6‐phosphate dehydrogenase deficiency complicated by indirect …

M Rezaie, R Gholami, M Jafari… - Journal of Paediatrics …, 2021 - Wiley Online Library
Aim This study aimed to investigate the effect of adding ursodeoxycholic acid (UDCA) to
phototherapy in neonates with glucose‐6‐phosphate dehydrogenase (G6PD) deficiency …

Attenuation of neuro-inflammation improves survival and neurodegeneration in a mouse model of severe neonatal hyperbilirubinemia

S Vodret, G Bortolussi, A Iaconcig, E Martinelli… - Brain, behavior, and …, 2018 - Elsevier
All pre-term newborns and a high proportion of term newborns develop neonatal jaundice.
Neonatal jaundice is usually a benign condition and self-resolves within few days after birth …

[HTML][HTML] Neuroprotective Effect of ω-3 Polyunsaturated Fatty Acids on Bilirubin Encephalopathy In Vitro and In Vivo

W Hao, J Song, G Li - … Medical Journal of Experimental and Clinical …, 2018 - ncbi.nlm.nih.gov
Background Bilirubin encephalopathy is a serious complication in neonatal jaundice and is
associated with high mortality and disability in newborns. The present study aimed to …

Therapeutic effects of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a randomized double-blind clinical trial

I Shahramian, K Tabrizian, P Ostadrahimi… - … and Critical Care, 2019 - aacc.tums.ac.ir
Background: Ursodeoxycholic acid (UDCA) is a safe drug used in the treatment of
cholestatic liver disorders in children. The aim of this study was to investigate the synergistic …

Bilirubin selectively inhibits cytochrome c oxidase activity and induces apoptosis in immature cortical neurons: assessment of the protective effects of …

AR Vaz, M Delgado‐Esteban, MA Brito… - Journal of …, 2010 - Wiley Online Library
J. Neurochem.(2010) 112, 56–65. Abstract High levels of unconjugated bilirubin (UCB) may
initiate encephalopathy in neonatal life, mainly in pre‐mature infants. The molecular …

Neonatal Hyperbilirubinemia: in vivo Characterization of Mechanisms of Bilirubin Neurotoxicity and Pharmacological Treatments

S Vodret - 2016 - oro.open.ac.uk
Neonatal jaundice or hyperbilirubinemia is the result of alterations in the bilirubin
metabolism. Prolonged and uncontrolled high levels of unconjugated bilirubin lead to …